Walker Carcinoma 256 is a type of cancer cell line widely used in research. The IPA phonetic transcription of this term is /ˈwɔːkər kɑːrsᵻˈnoʊmə ˈtuː fɪv sɪks/. The name "Walker" comes from the investigator who first developed this line. "Carcinoma" refers to the category of cancer that originates in epithelial tissues. The number "256" is simply the identifier of the particular line within the group of Walker carcinomas. Understanding the phonetic spelling of this word can help researchers properly identify and communicate about this important tool in cancer research.
Walker Carcinoma 256 is a widely studied and extensively utilized tumor cell line in cancer research. It is named after Thomas D. Walker, a renowned researcher who first isolated this particular type of tumor cell in 1928. Walker Carcinoma 256 is a rapidly growing sarcoma originating from a rat's fibrosarcoma induced by direct implantation of the tumor in the muscular tissues.
This tumor cell line has been extensively used in various experimental studies, including cancer biology, genetics, immunology, pharmacology, and therapy development. It serves as a valuable model for investigating tumor growth, metastasis, and response to various anticancer treatments.
Walker Carcinoma 256 exhibits several distinct characteristics that make it a particularly suitable model for cancer research. These characteristics include a high rate of growth, ability to metastasize to distant sites, and resistance to certain anticancer drugs. Additionally, this cell line has been observed to display an uneven pattern of growth during transplantation, with a tendency to infiltrate surrounding tissues.
Due to its well-documented and reproducible behavior, Walker Carcinoma 256 has become a widely accepted and standardized tumor cell line in scientific research. It serves as an indispensable tool for understanding the complexities of various cancer-related processes and evaluating potential treatments or therapeutic approaches aimed at combatting malignant tumors.